Revma-Heel

General characteristics. Structure:

Active ingredients: 60 mg of Rhus toxicodendron D6, 60 mg of Bryonia D4, 60 mg of Causticum Hahnemanni D4, 60 mg of Arnica montana D4, 60 mg of Ferrum phosphoricum D6 in 1 tablet.

Excipients: magnesium stearate, lactose monohydrate.

Indications to use:

Rheumatic diseases of soft tissues; (feather) artritny frustration.

Route of administration and doses:

For adults — 1 tablet on reception to accept sublingual (to rassasyvat under language) 3 times a day in 15 min. prior to meal or in one hour later.

Course of treatment – 2-4 weeks.

Features of use:

Drug contains lactose therefore to patients with rare hereditary forms of intolerance of a galactose, insufficiency of lactase or a syndrome of glyukozo-galaktozny malabsorption it is impossible to use drug.

Use during pregnancy or feeding by a breast. Through insufficiency of the appropriate documented experience of use drug can be used during pregnancy and feeding by a breast only after consultation with the doctor.

Ability to influence speed of response at control of motor transport or work with other mechanisms. It is unknown.

Children. Through insufficiency of the appropriate documented experience of use of drug for children, this medicine it is not recommended to apply in this age category.

Side effects:

Gastrointestinal and skin reactions including in several days after administration of drug are in some cases possible.

Interaction with other medicines:

It is not known.

Contraindications:

Hypersensitivity to Rhus toxicodendron, etc. to drug components.

Overdose:

It was not noted.

Storage conditions:

Period of validity - 5 years. To store in original packaging at a temperature not above 25 °C. To close a container with tablets immediately after use, to protect from moisture. To store in the place, unavailable to children.

Issue conditions:

Without recipe

Packaging:

Polypropylene container on 50 tablets in a cardboard box.